摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-bromo-2-(methylsulfanyl)benzaldehyde O-methyloxime | 1192347-59-3

中文名称
——
中文别名
——
英文名称
5-bromo-2-(methylsulfanyl)benzaldehyde O-methyloxime
英文别名
1-(5-bromo-2-methylsulfanylphenyl)-N-methoxymethanimine
5-bromo-2-(methylsulfanyl)benzaldehyde O-methyloxime化学式
CAS
1192347-59-3
化学式
C9H10BrNOS
mdl
——
分子量
260.154
InChiKey
JWUWIPUUBGFKGS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    46.9
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • Iminopyridine derivatives and use thereof
    申请人:Takeda Pharmaceutical Company Limited
    公开号:US07982044B2
    公开(公告)日:2011-07-19
    The present invention aims to provide an iminopyridine derivative compound having an α1D adrenergic receptor antagonistic action, which is useful as an agent for the prophylaxis or treatment of a lower urinary tract disease and the like. The present invention provides a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
    本发明旨在提供一种具有α1D肾上腺素受体拮抗作用的咪唑吡啶衍生物化合物,其可用作预防或治疗下尿路疾病等药物。本发明提供了一种由式所表示的化合物,其中每个符号如规范中所定义,或其盐。
  • Iminopyridine derivatives and uses thereof
    申请人:Takeda Pharmaceutical Company Limited
    公开号:US07985863B2
    公开(公告)日:2011-07-26
    The present invention aims to provide an iminopyridine derivative compound having an α1D adrenergic receptor antagonistic action, which is useful as an agent for the prophylaxis or treatment of a lower urinary tract disease and the like. The present invention provides a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
    本发明旨在提供一种具有α1D肾上腺素受体拮抗作用的亚胺吡啶衍生物化合物,该化合物可用作预防或治疗下尿路疾病等药物。本发明提供的化合物由下式表示:其中每个符号如规范中所定义,或其盐。
  • IMINOPYRIDINE DERIVATIVES AND USE THEREOF
    申请人:YOSHIDA Masato
    公开号:US20110124874A1
    公开(公告)日:2011-05-26
    The present invention aims to provide an iminopyridine derivative compound having an α 1D adrenergic receptor antagonistic action, which is useful as an agent for the prophylaxis or treatment of a lower urinary tract disease and the like. The present invention provides a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
    本发明旨在提供一种具有α1D肾上腺素能受体拮抗作用的吲哚啉衍生物化合物,其可用作预防或治疗下尿路疾病等药物。本发明提供一种由以下式表示的化合物,其中每个符号如规范中所定义,或其盐。
  • IMINOPYRIDINE DERIVATIVES AND USES THEREOF
    申请人:YOSHIDA Masato
    公开号:US20110124875A1
    公开(公告)日:2011-05-26
    The present invention aims to provide an iminopyridine derivative compound having an α 1D adrenergic receptor antagonistic action, which is useful as an agent for the prophylaxis or treatment of a lower urinary tract disease and the like. The present invention provides a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
    本发明旨在提供一种具有α1D肾上腺素能受体拮抗作用的咪唑吡啶衍生物化合物,其作为预防或治疗下尿路疾病等药物是有用的。本发明提供了一种由下式表示的化合物,其中每个符号如规范中所定义,或其盐。
  • Iminopyridine Derivatives and Use Thereof
    申请人:YOSHIDA MASATO
    公开号:US20090270393A1
    公开(公告)日:2009-10-29
    The present invention aims to provide an iminopyridine derivative compound having an α 1D adrenergic receptor antagonistic action, which is useful as an agent for the prophylaxis or treatment of a lower urinary tract disease and the like. The present invention provides a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
    本发明旨在提供一种具有α1D肾上腺素受体拮抗作用的咪唑啉衍生物化合物,该化合物可用作预防或治疗下尿路疾病等疾病的药剂。本发明提供了一种由下式表示的化合物或其盐:其中每个符号如规范中定义。
查看更多